Effects of a new calcium antagonist, mibefradil (Ro 40–5967), on silent ischemia in patients with stable chronic angina pectoris: A multicenter placebo-controlled study
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 27 (2), 317-322
- https://doi.org/10.1016/0735-1097(95)00472-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Myocardial ischemia during daily activities: The importance of increased myocardial oxygen demandJournal of the American College of Cardiology, 1991
- Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: Importance of the exercise protocolJournal of the American College of Cardiology, 1991
- Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectorisThe American Journal of Cardiology, 1990
- Ischemia in the ambulatory setting—The total ischemic burden: Relation to exercise testing and investigative and therapeutic implicationsJournal of the American College of Cardiology, 1989
- Combined Use of Calcium-Channel and Beta-Adrenergic Blockers for the Treatment of Chronic Stable AnginaAnnals of Internal Medicine, 1988
- Features of the exercise test that reflect the activity of ischemic heart disease out of hospital.Circulation, 1986
- Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease. Investigation of the frequency of nocturnal ischaemia and coronary spasm.Heart, 1985
- MYOCARDIAL ISCHAEMIA DURING DAILY LIFE IN PATIENTS WITH STABLE ANGINA: ITS RELATION TO SYMPTOMS AND HEART RATE CHANGESThe Lancet, 1983
- Comparison of electrocardiographic and left ventricular functional changes during exercise.Circulation, 1980
- Early detection of silent ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects.Heart, 1974